scholarly journals Identifying Diabetic Macular Edema and Other Retinal Diseases by Optical Coherence Tomography Image and Multiscale Deep Learning

2020 ◽  
Vol Volume 13 ◽  
pp. 4787-4800
Author(s):  
Quan Zhang ◽  
Zhiang Liu ◽  
Jiaxu Li ◽  
Guohua Liu
Keyword(s):  
Optical Coherence Tomography ◽  
Deep Learning ◽  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Optical Coherence Tomography Image ◽  
Retinal Diseases ◽  
Optical Coherence ◽  
Tomography Image

scholarly journals Optical coherence tomography image for automatic classification of diabetic macular edema

2020 ◽  
Vol 50 (4) ◽  
Author(s):  
Ping Wang ◽  
Jia-Li Li ◽  
Hao Ding
Keyword(s):  
Optical Coherence Tomography ◽  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Automatic Classification ◽  
Training Data ◽  
Fine Tuning ◽  
Optical Coherence Tomography Image ◽  
Optical Coherence ◽  
Data Set ◽  
Tomography Image

Diabetic macular edema (DME) is the dominant reason of diabetic visual loss, so early detection and treatment of DME is of great significance for the treatment of diabetes. Based on transfer learning, an automatic classification method is proposed to distinguish DME images from normal images in optical coherence tomography (OCT) retinal fundus images. Features of the DME are automatically identified and extracted by the pre-trained convolutional neural network (CNN), which only involves fine-tuning the VGGNet-16 network without any user intervention. An accuracy of 97.9% and a sensitivity of 98.0% are acquired with the OCT images in the Duke data set from experimental results. The proposed method, a core part of an automated diagnosis system of the DME, revealed the ability of fine-tuning models to train non-medical images, allowing them can be classified with limited training data. Moreover, it can be developed to assist early diagnosis of the disease, effectively delaying (or avoiding) the progression of the disease, consequently.

scholarly journals A Multitask Deep-Learning System to Classify Diabetic Macular Edema for Different Optical Coherence Tomography Devices: A Multicenter Analysis

2021 ◽  
Author(s):  
Fangyao Tang ◽  
Xi Wang ◽  
An-ran Ran ◽  
Carmen KM Chan ◽  
Mary Ho ◽  
...  
Keyword(s):  
Optical Coherence Tomography ◽  
Deep Learning ◽  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Vision Loss ◽  
Three Dimensional ◽  
Learning System ◽  
Optical Coherence ◽  
Automated Classification

<a><b>Objective:</b></a> Diabetic macular edema (DME) is the primary cause of vision loss among individuals with diabetes mellitus (DM). We developed, validated, and tested a deep-learning (DL) system for classifying DME using images from three common commercially available optical coherence tomography (OCT) devices. <p><b>Research Design and Methods:</b> We trained and validated two versions of a multi-task convolution neural network (CNN) to classify DME (center-involved DME [CI-DME], non-CI-DME, or absence of DME) using three-dimensional (3D) volume-scans and two-dimensional (2D) B-scans respectively. For both 3D and 2D CNNs, we employed the residual network (ResNet) as the backbone. For the 3D CNN, we used a 3D version of ResNet-34 with the last fully connected layer removed as the feature extraction module. A total of 73,746 OCT images were used for training and primary validation. External testing was performed using 26,981 images across seven independent datasets from Singapore, Hong Kong, the US, China, and Australia. </p> <p><b>Results:</b> In classifying the presence or absence of DME, the DL system achieved area under the receiver operating characteristic curves (AUROCs) of 0.937 (95% CI 0.920–0.954), 0.958 (0.930–0.977), and 0.965 (0.948–0.977) for primary dataset obtained from Cirrus, Spectralis, and Triton OCTs respectively, in addition to AUROCs greater than 0.906 for the external datasets. For the further classification of the CI-DME and non-CI-DME subgroups, the AUROCs were 0.968 (0.940–0.995), 0.951 (0.898–0.982), and 0.975 (0.947–0.991) for the primary dataset and greater than 0.894 for the external datasets. </p> <p><b>Conclusion:</b> We demonstrated excellent performance with a DL system for the automated classification of DME, highlighting its potential as a promising second-line screening tool for patients with DM, which may potentially create a more effective triaging mechanism to eye clinics. </p>

scholarly journals Significance of Hyperreflective Foci as an Optical Coherence Tomography Biomarker in Retinal Diseases: Characterization and Clinical Implications

2021 ◽  
Vol 2021 ◽  
pp. 1-10
Author(s):  
Serena Fragiotta ◽  
Solmaz Abdolrahimzadeh ◽  
Rosa Dolz-Marco ◽  
Yoichi Sakurada ◽  
Orly Gal-Or ◽  
...  
Keyword(s):  
Optical Coherence Tomography ◽  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Pigment Epithelium ◽  
Retinal Pigment ◽  
Age Related Macular Degeneration ◽  
Retinal Diseases ◽  
Optical Coherence ◽  
Hyperreflective Foci ◽  
Age Related

Hyperreflective foci (HRF) is a term coined to depict hyperreflective dots or roundish lesions within retinal layers visualized through optical coherence tomography (OCT). Histopathological correlates of HRF are not univocal, spacing from migrating retinal pigment epithelium cells, lipid-laden macrophages, microglial cells, and extravasated proteinaceous or lipid material. Despite this, HRF can be considered OCT biomarkers for disease progression, treatment response, and prognosis in several retinal diseases, including diabetic macular edema, age-related macular degeneration (AMD), retinal vascular occlusions, and inherited retinal dystrophies. The structural features and topographic location of HRF guide the interpretation of their significance in different pathological conditions. The presence of HRF less than 30 μm with reflectivity comparable to the retinal nerve fiber layer in the absence of posterior shadowing in diabetic macular edema indicates an inflammatory phenotype with a better response to steroidal treatment. In AMD, HRF overlying drusen are associated with the development of macular neovascularization, while parafoveal drusen and HRF predispose to macular atrophy. Thus, HRF can be considered a key biomarker in several common retinal diseases. Their recognition and critical interpretation via multimodal imaging are vital to support clinical strategies and management.

Sign in / Sign up

Export Citation Format

Share Document